Quest Laboratories (NSE:QUESTLAB) Debt-to-Asset : 0.07 (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹91.20
! 7 Warning Signs
View Full Analysis

What is Quest Laboratories Debt-to-Asset?

Quest Laboratories NSE:QUESTLAB +2.47% 44 Debt-to-Asset is 0.07 as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 7 warning signs investors should review.

Quest Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹70 Mil. Quest Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹9 Mil. Quest Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was ₹1,112 Mil. Quest Laboratories's debt to asset for the quarter that ended in Mar. 2026 was 0.07.

Quest Laboratories  (NSE:QUESTLAB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Quest Laboratories Debt-to-Asset Related Terms

Quest Laboratories Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Debt-to-Asset Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Asset
Get a 7-Day Free Trial 0.09 0.09 0.08 0.25 0.07

Quest Laboratories Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only 0.08 0.00 0.25 0.24 0.07

NSE:QUESTLAB vs LLY, JNJ, ABBV: Debt-to-Asset Comparison

For the Drug Manufacturers - General subindustry, Quest Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest Laboratories Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's Debt-to-Asset falls into.


NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Quest Laboratories's Debt-to-Asset for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(69.759 + 9.094) / 1111.504
=0.07

Quest Laboratories's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(69.759 + 9.094) / 1111.504
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.07 mean?
Quest Laboratories (NSE:QUESTLAB) has a Debt-to-Asset of 0.07 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Debt-to-Asset too high?
Quest Laboratories' current Debt-to-Asset is 0.07. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Debt-to-Asset compare to LLY and JNJ?
Quest Laboratories' Debt-to-Asset of 0.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Debt-to-Asset is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Debt-to-Asset of 0.07. The current Debt-to-Asset is 0.07. Quest Laboratories' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Debt-to-Asset is 0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹91.20
Price